China’s drug regulator has approved MPox’s vaccine for clinical trials
China’s drug regulator has approved the MPox vaccine for clinical trials. This vaccine, developed by China’s local pharmaceutical firm Sinopharm, has been approved for clinical trials by the top drug regulator. This will be the country’s first experimental dose to fight this deadly disease. The domestically developed Ampox vaccine, manufactured by the Shanghai Institute of